Alpha Cubed Investments’s Cymabay Therapeutics CBAY Stock Holding History

Alpha Cubed Investments’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-20,000	Closed	-$115K	–	244
2017 Q2	$115K	Hold	20,000	–	–	0.02%	203
2017 Q1	$86K	Hold	20,000	–	–	0.02%	186
2016 Q4	$35K	Hold	20,000	–	–	0.01%	187
2016 Q3	$39K	Hold	20,000	–	–	0.01%	176
2016 Q2	$35K	Hold	20,000	–	–	0.01%	144
2016 Q1	$27K	Hold	20,000	–	–	0.01%	158
2015 Q4	$34K	Hold	20,000	–	–	0.01%	175
2015 Q3	$31K	Hold	20,000	–	–	0.01%	188
2015 Q2	$54K	Hold	20,000	–	–	0.01%	181
2015 Q1	$138K	Hold	20,000	–	–	0.04%	171
2014 Q4	$197K	Hold	20,000	–	–	0.08%	134
2014 Q3	$137K	Buy	+20,000	New	+$123K	0.06%	143

Other funds holding CBAY

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Alpha Cubed Investments's CBAY Position: Q3 2017 in Review

Alpha Cubed Investments sold out of Cymabay Therapeutics (CBAY) in Q3 2017, closing a stake of 20,000 shares — an estimated $115K sold.

Alpha Cubed Investments first reported a position in CBAY in Q3 2014 and held it in 12 quarters. The position peaked at $197K in Q4 2014. 64 funds tracked by Wall St. Rank hold CBAY as of Q3 2017.

Alpha Cubed Investments reported no remaining Cymabay Therapeutics position as of Q3 2017 after selling out during the quarter.
Alpha Cubed Investments sold 20,000 Cymabay Therapeutics shares in Q3 2017, an estimated $115K.
Alpha Cubed Investments first reported a position in Cymabay Therapeutics in Q3 2014 and held it in 12 quarters.
Alpha Cubed Investments's Cymabay Therapeutics position peaked at $197K in Q4 2014.
64 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q3 2017.

Based on Alpha Cubed Investments's 13F filing for Q3 2017, filed 23 Oct 2017.